Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
737,449
-
Total 13F shares
-
457,636
-
Share change
-
+423,563
-
Total reported value
-
$1,509,962
-
Price per share
-
$3.30
-
Number of holders
-
12
-
Value change
-
+$1,397,969
-
Number of buys
-
7
Institutional Holders of InMed Pharmaceuticals Inc. - Common Stock (INM) as of Q1 2021
As of 31 Mar 2021 InMed Pharmaceuticals Inc. - Common Stock (INM) had 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 457,636 shares of stock of the company.
Largest 10 holders included ARMISTICE CAPITAL, LLC, Hudson Bay Capital Management LP, CITADEL ADVISORS LLC, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, Creative Planning, The PNC Financial Services Group, Inc., UBS Group AG, REILLY FINANCIAL ADVISORS, LLC, and ROYAL BANK OF CANADA.
This table shows 12 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.